This pathway diagram is derived from Figure 6c in "The human immune response to tuberculosis and its treatment: a view from the blood" (PMID: 25703554, [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368415 PMC4368415]).
Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP4197 CPTAC Assay Portal].
ea4
bdc
e70
e3b
23940611
PubMed
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.
PLoS One
2013
Bloom CI
Graham CM
Berry MP
Rozakeas F
Redford PS
Wang Y
Xu Z
Wilkinson KA
Wilkinson RJ
Kendrick Y
Devouassoux G
Ferry T
Miyara M
Bouvry D
Valeyre D
Gorochov G
Blankenship D
Saadatian M
Vanhems P
Beynon H
Vancheeswaran R
Wickremasinghe M
Chaussabel D
Banchereau J
Pascual V
Ho LP
Lipman M
O'Garra A
25703554
PubMed
The human immune response to tuberculosis and its treatment: a view from the blood.
Immunol Rev
2015
Cliff JM
Kaufmann SH
McShane H
van Helden P
O'Garra A
tuberculosis
DOID:399
Disease
20725040
PubMed
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.
Nature
2010
Berry MP
Graham CM
McNab FW
Xu Z
Bloch SA
Oni T
Wilkinson KA
Banchereau R
Skinner J
Wilkinson RJ
Quinn C
Blankenship D
Dhawan R
Cush JJ
Mejias A
Ramilo O
Kon OM
Pascual V
Banchereau J
Chaussabel D
O'Garra A
22872737
PubMed
Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response.
J Infect Dis
2013
Cliff JM
Lee JS
Constantinou N
Cho JE
Clark TG
Ronacher K
King EC
Lukey PT
Duncan K
Van Helden PD
Walzl G
Dockrell HM
immune response pathway
PW:0000023
Pathway Ontology